Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024ESMO OpenOpen Access

5P IDH1 mutation status and overall survival in glioblastoma patients: A meta-analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

RARana Al-ShimiRORamez M. OdatZSZaid Shakhatreh

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Al-Shimi et al. (2024) studied this question.

synapsesocial.com/papers/68e76923b6db6435876dece1https://doi.org/10.1016/j.esmoop.2024.102395
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-term survivors in 976 supratentorial glioblastoma, IDH-wildtype patients2024 · 17 citations
  2. 2MGMT promoter methylation in prognosis of patients with newly diagnosed IDH1 wildtype Glioblastoma2024
  3. 3Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma2024 · 4 citations
  4. 4Brainstem Gliomas With Isocitrate Dehydrogenase Mutation: Natural History, Clinical-Radiological Features, Management Strategy, and Long-Term Outcome2024 · 8 citations
  5. 5Survival Determinants in Glioblastoma: An Insight into Biopsy-Only Patient Outcomes2024